Schedule 13G ownership disclosure

GALERA THERAPEUTICS INC

Security class unavailable · CUSIP: 36338D108

Event date: 2024-04-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
10.8990%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-24-044069
Form type
SC 13G
Filer
Galera Therapeutics, Inc.
CIK
CIK 1563577
Filed
May 16, 2024
Reporting period
Apr 16, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub